FATE THERAPEUTICS INC

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting

22 أبريل 2024 15:30:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference

03 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

02 أبريل 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

19 مارس 2024 07:44:41 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

07 مارس 2024 14:11:47 بحسب NetDania Notify

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

05 مارس 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming March Investor Conferences

01 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

27 فبراير 2024 08:45:16 بحسب NetDania Notify

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

26 فبراير 2024 15:01:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

16 فبراير 2024 09:00:35 بحسب NetDania Notify

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

15 فبراير 2024 09:31:27 بحسب NetDania Notify

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

15 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02 فبراير 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

08 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 ديسمبر 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

08 نوفمبر 2023 15:01:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results

25 أكتوبر 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming September Investor Conferences

31 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

08 أغسطس 2023 15:01:00 بحسب Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results

28 يوليو 2023 07:00:00 بحسب Nasdaq GlobeNewswire